Arkolith/Insider Trading/PHGE/Form 4

Oron Assaf

Chief Business OfficerBiomX Inc. (PHGE) · full profile →Form 4 · filed Oct 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 29, 2023Grant(A)47K—$00
Oct 29, 2023Disposed to issuer(D)47K—$00
Oct 29, 2023Grant(A)83K—$00
Oct 29, 2023Disposed to issuer(D)83K—$00
Oct 29, 2023Grant(A)155K—$00
Oct 29, 2023Disposed to issuer(D)155K—$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-081857) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML